CFDE Data Portal | Search FGD5P1

	Label	Description
	FGD5P1 associations Collection (Entity type)	Associations for FGD5P1_associations
	FGD5P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	FGD5P1 Gene (Entity type)	ENSG00000290338 - FYVE, RhoGEF and PH domain containing 5 pseudogene 1
	GSE193739 CGA knockdown 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE139016 disulfiram 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126651 PRMT5 MTAP inhibition 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE193541 nifurtimox A-549 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Pancreas 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx SmallIntestine 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Brain 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx

FGD5P1 associations

Associations for FGD5P1_associations

FGD5P1 associations.tsv

A file from IDG as part of the Harmonizome project

FGD5P1

ENSG00000290338 - FYVE, RhoGEF and PH domain containing 5 pseudogene 1

GSE193739 CGA knockdown 2 v 1 human dn

A Gene Set from LINCS

GSE139016 disulfiram 3 v 1 human dn

A Gene Set from LINCS

GSE126651 PRMT5 MTAP inhibition 1 v 2 human up

A Gene Set from LINCS

GSE193541 nifurtimox A-549 0 v 3 human up

A Gene Set from LINCS

GTEx Pancreas 20-29 vs 70-79 Down

A Gene Set from GTEx

GTEx SmallIntestine 20-29 vs 40-49 Down

A Gene Set from GTEx

GTEx Brain 20-29 vs 50-59 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.